In considering the genetic landscape of HNSCC, driver gene mutations, including frequently observed mutations in MYC, APC, TP53, and KRAS [42], play a pivotal role in shaping cancer immune phenotypes and tolerance [43]. This evidence concerns the gene TP53 and cancer.